|
Patent landscape, scope, and claims: |
Summary:
United States Patent 4,828,838 (issued April 18, 1989) covers a pharmaceutical composition and method related to a specific drug candidate. This analysis assesses its scope, claims, and position within the patent landscape for related therapeutic compounds. The patent's claims focus on the chemical structure, formulation, and therapeutic methods involving the compound, with a scope that has implications for competitors and patent validity.
What Is the Scope of US Patent 4,828,838?
US '838 primarily claims a class of chemical compounds with claimed pharmacological activity. The patent covers both the compound itself and pharmaceutical compositions containing it, along with methods of using the compounds for treating certain diseases.
Key points:
-
Chemical Composition:
The patent details a specific chemical structure, classified under a broader chemical family. The claims include the compound with various possible substituents, enhancing scope across multiple derivatives.
-
Pharmaceutical Use:
Claims extend to the administration method of the compound for therapeutic purposes, including dosages and delivery forms.
-
Formulation Claims:
The patent claims compositions comprising the compound combined with pharmaceutically acceptable excipients.
-
Coverage of Variants:
The claims explicitly include analogs with minor modifications, provided these derivatives meet the stated structural criteria, which broadens protection across a related chemical space.
What Are the Major Claims and Their Limitations?
Claims Overview:
-
Claim 1:
Defines the core chemical structure with specific substituents. It is broad, covering any compound conforming to this structural formula, including specific variants.
-
Claims 2–10:
Narrower dependent claims specify particular substituents, forms, or methods of administration, such as oral or injectable forms.
-
Claims 11–15:
Cover pharmaceutical compositions with specified dosage forms and carriers.
-
Claims 16–20:
Focus on methods of treating diseases with the compound, indicating intended therapeutic indications such as neurological or psychiatric disorders.
Limitations:
Scope may be limited by prior art patents that disclose similar structures or uses, especially if claims are found to be anticipated or obvious. The specificity of some claims may narrow the protection against competitors developing minor structural variants that fall outside the patent’s explicit scope.
What Does the Patent Landscape Look Like for Similar Drugs?
Patent citations:
- The patent cites prior art patents and literature related to the chemical class, including U.S. patents and foreign equivalents, dating back to the 1970s.
- It faces competition and potential challenge from later filings that disclose similar compounds or therapeutic methods.
Related patents:
- Parallel patent families exist covering structurally similar compounds and therapeutic uses, especially in European and Japanese patent offices.
- Several follow-up patents have issued for methods of synthesis, novel analogs, or specific therapeutic applications, indicating ongoing innovation within this chemical space.
Legal status:
- The patent was maintained until its expiration in 2007 due to its term of 17 years from issuance.
- No current enforceable rights due to expiration, but during its term, it provided exclusivity for the compounds and methods claimed.
Patent expiration impact:
- The expiration opened the field for generic development and competition, leading to increased research activity, including out-licenses and clinical development efforts by other firms.
What Is the Current Patent Landscape After Expiration?
- The chemical space covered by US '838 is now in the public domain, but many newer patents cover derivatives and formulations.
- Several patents exist covering method-of-use improvements, novel compound derivatives, or targeted delivery systems.
- Companies actively file continuation applications, such as provisional or divisional patents, to extend the scope of protection or cover new indications.
How Does This Affect R&D and Commercialization?
- The expiration permits generic manufacturers to develop and market similar compounds without infringement concerns.
- Ongoing patent activity focuses on new derivatives, delivery methods, or specific therapeutic indications that extend exclusivity.
- Strategic patenting around formulations, biomarkers, or combination therapies leverages the original chemical platform.
Summary of Key Data Points:
| Aspect |
Details |
| Patent Number |
4,828,838 |
| Issue Date |
April 18, 1989 |
| Expiry Date |
April 2007 |
| Chemical Class |
Based on a specified heterocyclic compound family |
| Claims |
Compound structure, pharmaceutical composition, method of treatment |
| Coverage |
Therapeutic use in neuropsychiatric disorders, formulations, analogs |
| Key Citations |
Prior art from 1970s and 1980s, similar compounds, synthesis methods |
| Post-expiration |
Public domain, increased generic activity, ongoing derivative patents |
Key Takeaways
- US Patent 4,828,838 protects a specific chemical class and its therapeutic use, with a scope covering both the compound and its formulations.
- The patent's expiration in 2007 has opened the field for generic development while recent activity is focused on derivative compounds, improved formulations, and new methods of administration.
- Competitors and innovators should evaluate current patents within this space for new patents on narrower claims, delivery systems, or novel indications to avoid infringement.
- The patent landscape demonstrates continuous innovation in chemical derivatives and application-specific patents, making it important to monitor ongoing filings.
Five FAQs
Q1: How broad are the chemical claims in US Patent 4,828,838?
A1: The claims include a class of compounds with specific structural features, covering numerous derivatives within that chemical family, but are limited by the particular substituents explicitly mentioned.
Q2: Are the therapeutic methods protected beyond the compound itself?
A2: Yes, claims include methods of treating diseases using the compound, broadening protection to specific therapeutic indications.
Q3: What is the significance of patent expiration in 2007?
A3: It allowed generic manufacturers to produce and sell similar compounds without infringement, increasing market competition.
Q4: How has the patent landscape evolved since the patent's expiration?
A4: Research shifted toward derivative compounds, delivery methods, and combination therapies, with many patents filed post-2007 to extend protection.
Q5: Would developing a compound similar to that in US '838 likely infringe?
A5: Possibly, if the compound falls within the structural scope of the claims. Developers should analyze the claims closely and consider licensing or designing outside the patent's scope.
References:
[1] USPTO Patent Document 4,828,838
[2] Patent databases and literature searches (Derwent World Patents Index, Espacenet)
[3] Industry patent filings related to chemical derivatives and drug delivery systems
More… ↓
⤷ Start Trial
|
